Intuitive Surgical (NASDAQ:ISRG) PT Raised to $512.00

Intuitive Surgical (NASDAQ:ISRG) had its target price hoisted by stock analysts at Citigroup from $462.00 to $512.00 in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Citigroup’s price objective would indicate a potential upside of 15.45% from the stock’s current price.

Several other research analysts have also recently commented on the company. Piper Sandler boosted their price target on Intuitive Surgical from $435.00 to $490.00 and gave the stock an “overweight” rating in a research note on Tuesday. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a research report on Friday, April 19th. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Evercore ISI increased their price objective on shares of Intuitive Surgical from $385.00 to $425.00 and gave the company an “in-line” rating in a research note on Tuesday, July 2nd. Finally, Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday, April 19th. Six research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $410.32.

Intuitive Surgical Stock Down 0.3 %

NASDAQ ISRG opened at $443.50 on Wednesday. The stock has a market cap of $157.31 billion, a PE ratio of 80.05, a P/E/G ratio of 5.74 and a beta of 1.39. The business has a 50 day moving average price of $415.83 and a two-hundred day moving average price of $389.66. Intuitive Surgical has a fifty-two week low of $254.85 and a fifty-two week high of $449.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same period last year, the business earned $1.00 EPS. The business’s revenue was up 11.5% on a year-over-year basis. Sell-side analysts anticipate that Intuitive Surgical will post 4.8 EPS for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 5,318 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total value of $1,971,169.88. Following the completion of the transaction, the executive vice president now owns 298 shares in the company, valued at approximately $110,456.68. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Craig H. Barratt sold 2,496 shares of the company’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $402.89, for a total value of $1,005,613.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 5,318 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the transaction, the executive vice president now directly owns 298 shares in the company, valued at approximately $110,456.68. The disclosure for this sale can be found here. Insiders have sold a total of 17,956 shares of company stock valued at $6,927,011 in the last quarter. Company insiders own 0.80% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ISRG. Creekmur Asset Management LLC boosted its stake in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares in the last quarter. Delos Wealth Advisors LLC boosted its stake in Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares in the last quarter. LRI Investments LLC acquired a new position in Intuitive Surgical during the first quarter worth about $30,000. Baystate Wealth Management LLC raised its position in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares in the last quarter. Finally, MCF Advisors LLC lifted its holdings in Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 40 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.